A Study of Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009)

Summary

This study aims to assess the safety, tolerability, and pharmacokinetics (PK) of oral doses of surotomycin (CB-183,315) administered for 14 consecutive days in healthy males and females.

Timeline

Start

2009-07

Primary completion

2009-10

Completion

2009-10

Publications

• Chandorkar G, Zhan Q, Donovan J, Rege S, Patino H. Pharmacokinetics of surotomycin from phase 1 single and multiple ascending dose studies in healthy volunteers. BMC Pharmacol Toxicol. 2017 Mar 28;18(1):24. doi: 10.1186/s40360-017-0123-z.

Drugs

Indications